港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

映恩生物-B

335.400

-13.400-3.84%

成交量：12.44万

成交额：4,244.92万

市值：295.27亿

市盈率：-2.34

高：355.400

开：351.000

低：333.200

收：348.800

52周最高：406.000

52周最低：165.500

股本：8,803.63万

香港流通股本：8,803.63万

量比：1.09

换手率：0.14%

股息：- -

股息率：- -

每股收益(LYR):-143.299

净资产收益率：--

总资产收益率：-6.51%

市净率：-13.34

市盈率(LYR):-2.34

市销率: 13.94

数据加载中...

总览公司新闻公告

恒生指数有限公司宣布指数检讨结果

映恩生物－Ｂ(09606)出现大手买入2.5万股，成交价$357.4，涉资893.5万

阿斯达克财经

每日卖空追踪 | 映恩生物-B 08月11日卖空量成交5200股，卖空比例为4.05%

医药行业周报：礼来口服减肥药疗效低于预期关注中国创新减肥药研发和出海进展

每日卖空追踪 | 映恩生物-B 08月08日卖空量成交5400股，卖空比例为3.18%

MSCI全球小型股指数调整在即映恩生物-B(09606)等将被纳入

映恩生物-B08月07日主力净流出178.2万元散户资金买入

【IPO前哨】再次递表！旺山旺水生物估值超44亿，这些点值得关注

映恩生物-B08月05日主力净流入221.8万元散户资金抛售

苏州基金：医疗投资八年征途

医药行业周报：IO2.0赛道进展喜人静待下半年产业催化

创新药东风浩荡：科创板未盈利IPO重新开闸

映恩生物-B08月01日主力净流出607.8万元散户资金买入

映恩生物-B07月29日主力净流入398.3万元散户资金抛售

“冠科系”新锐冲击港交所，翰思艾泰的“下一代双抗免疫治疗”能否大放异彩？

三生制药与辉瑞全球授权协议生效|先声再明FDA获批临床|映恩生物新一代HER3获FDA快速通道资格

中国医药创新促...

中国创新药出海“爆单”，半年揽660亿美元

中国企业家杂志

当3000亿资金涌向18A新股

映恩生物-B07月24日获主力加仓245.1万元

1500万美元首付款，又一款国产CAR-T出海；赛诺菲16亿美元收购疫苗企业

Ofweek光电信息网

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/09606/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09606","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09606\",,,,,undefined,":{"symbol":"09606","market":"HK","secType":"STK","nameCN":"映恩生物-B","latestPrice":335.4,"timestamp":1756178610332,"preClose":348.8,"halted":0,"volume":124393,"delay":0,"floatShares":88036299,"shares":88036299,"eps":-143.2985104257297,"marketStatus":"交易中","change":-13.4,"latestTime":"08-26 11:24:16","open":351,"high":355.4,"low":333.2,"amount":42449237,"amplitude":0.063647,"askPrice":335.6,"askSize":300,"bidPrice":335.4,"bidSize":900,"shortable":3,"etf":0,"ttmEps":-143.29852133920136,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1756180800000},"marketStatusCode":2,"adr":0,"listingDate":1744646400000,"exchange":"SEHK","adjPreClose":348.8,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"volumeRatio":1.091844,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09606\",,,,,undefined,":{"symbol":"09606","floatShares":88036299,"roa":"-6.51%","roe":"--","lyrEps":-143.298521,"volumeRatio":1.091844,"shares":88036299,"dividePrice":0,"high":355.4,"amplitude":0.063647,"preClose":348.8,"low":333.2,"week52Low":165.5,"pbRate":"-13.34","psRate":"13.94","week52High":406,"institutionHeld":0,"latestPrice":335.4,"committee":0.5,"eps":-143.2985104257297,"divideRate":0,"volume":124393,"delay":0,"ttmEps":-143.29852133920136,"open":351,"prevYearClose":94.6,"prevWeekClose":342,"prevMonthClose":350.2,"prevQuarterClose":236.6,"fiveDayClose":334.8,"twentyDayClose":368,"sixtyDayClose":195},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09606\",params:#limit:5,,,undefined,":[{"date":"2025-08-26","symbol":"09606","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09606\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09606\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.8,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":5,"updateTime":1749830400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09606\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09606","date":"2025-08-25","current":-26.760141,"percent":0.144444,"low":-29.984477,"twenty":-25.772889,"median":-19.118727,"eighty":-15.806523,"high":-7.368305,"avg":-20.325606,"sd":4.933849,"marketCap":30707048883},"quantilePoints":[{"date":"2025-04-17","current":-14.905978,"twenty":-15.065639,"median":-14.442293,"eighty":-11.334487,"marketCap":16635152800},{"date":"2025-04-25","current":-15.846935,"twenty":-16.770434,"median":-15.576033,"eighty":-14.349556,"marketCap":17719522633},{"date":"2025-05-02","current":-16.438538,"twenty":-16.715855,"median":-16.124153,"eighty":-14.985809,"marketCap":18420101638},{"date":"2025-05-09","current":-15.074661,"twenty":-16.551291,"median":-15.826729,"eighty":-15.074661,"marketCap":17010399982},{"date":"2025-05-16","current":-15.043786,"twenty":-16.438538,"median":-15.220044,"eighty":-14.405796,"marketCap":17114249721},{"date":"2025-05-23","current":-16.495727,"twenty":-16.438538,"median":-15.262587,"eighty":-14.582474,"marketCap":18822153243},{"date":"2025-05-30","current":-16.208434,"twenty":-16.401371,"median":-15.460562,"eighty":-14.726132,"marketCap":18575651704},{"date":"2025-06-06","current":-16.427701,"twenty":-16.438538,"median":-15.666395,"eighty":-14.905978,"marketCap":18874975001},{"date":"2025-06-13","current":-20.940103,"twenty":-16.693343,"median":-15.893657,"eighty":-15.005253,"marketCap":24069114577},{"date":"2025-06-20","current":-18.479443,"twenty":-18.428819,"median":-16.104695,"eighty":-15.043786,"marketCap":21199132371},{"date":"2025-06-27","current":-18.0452,"twenty":-18.863356,"median":-16.282988,"eighty":-15.074661,"marketCap":20758951051},{"date":"2025-07-04","current":-21.227749,"twenty":-18.942282,"median":-16.427701,"eighty":-15.074735,"marketCap":24421259633},{"date":"2025-07-11","current":-22.045806,"twenty":-19.683704,"median":-16.508309,"eighty":-15.190609,"marketCap":25336836779},{"date":"2025-07-18","current":-25.758166,"twenty":-20.839221,"median":-16.693343,"eighty":-15.21995,"marketCap":29580184704},{"date":"2025-07-25","current":-25.970367,"twenty":-21.539184,"median":-16.981252,"eighty":-15.260218,"marketCap":29932329760},{"date":"2025-08-01","current":-24.963588,"twenty":-22.267132,"median":-18.096065,"eighty":-15.298157,"marketCap":28594178547},{"date":"2025-08-08","current":-27.998627,"twenty":-24.402884,"median":-18.454131,"eighty":-15.429476,"marketCap":32150843612},{"date":"2025-08-15","current":-27.487815,"twenty":-25.397092,"median":-18.863356,"eighty":-15.513126,"marketCap":31516982512},{"date":"2025-08-22","current":-26.341915,"twenty":-25.761111,"median":-19.052333,"eighty":-15.750472,"marketCap":30108402288},{"date":"2025-08-25","current":-26.760141,"twenty":-25.772889,"median":-19.118727,"eighty":-15.806523,"marketCap":30707048883}],"updateTime":1756178654281},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09606\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2561473161","title":"恒生指数有限公司宣布指数检讨结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2561473161","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561473161?lang=zh_cn&edition=fundamental","pubTime":"2025-08-22 18:20","pubTimestamp":1755858018,"startTime":"0","endTime":"0","summary":"金吾财讯 | 恒生指数有限公司今天宣布，截至2025年6月30日之恒生指数系列季度检讨结果，所有变动将于2025年9月5日 收市后实施并于2025年9月8日(星期一)起生效。成份股将加入中国电信，京东物流，泡泡玛特。恒生指数成份股的变动亦适用于恒指港股通指数。成份股将加入泡泡玛特；剔除极兔速递-W。","market":"us","thumbnail":"https://static.szfiu.com/news/20250106/MzNhMjUxNDI3Yzg1Yjg1NGVkN2ZhNDc2YWI2MTA4NTA5OTA5OTQ4.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/MzNhMjUxNDI3Yzg1Yjg1NGVkN2ZhNDc2YWI2MTA4NTA5OTA5OTQ4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1964666","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09992","SGXZ86797644.SGD","BK1589","HK0000252152.HKD","01519","BK1151","HK0000252160.HKD","HSTECH","LU0572944931.SGD","LU0345776255.USD","BK1604","02367","BK1100","LU0039217434.USD","02005","09606","00460","LU0345775950.USD","LU1770036033.HKD","BK1600","LU0499858438.USD","SG9999002950.SGD","BK1207","SG9999001069.SGD","LU2488822045.USD","SG9999004311.SGD","LU1481107354.HKD","BK1506","LU2460026573.USD","00728","LU0164865239.USD","LU0611395673.USD","LU0211977185.USD","01302","LU0823426480.USD","BK1536","LU0164880469.USD","LU0231483743.USD","LU0871576103.HKD","LU0348767384.USD","LU0327786744.USD","BK1161","LU0307460666.USD","LU0499858602.USD","SGXZ62798434.SGD","01513","BK1610","BK1224","02618","HK0000500386.USD"],"gpt_icon":1},{"id":"2559367127","title":"映恩生物－Ｂ(09606)出现大手买入2.5万股，成交价$357.4，涉资893.5万","url":"https://stock-news.laohu8.com/highlight/detail?id=2559367127","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559367127?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 13:40","pubTimestamp":1755063600,"startTime":"0","endTime":"0","summary":"[大手成交]映恩生物－Ｂ(09606)在下午01:40出现大手买入，成交量为2.5万，成交价为港币$357.4，涉资893.5万。至目前为止，股价升1.535%，今日最高价为$366.0，而最低价为$353.6，总成交量为12.339万股，总成交金额港币$4.418千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2508137615/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["HK0000252152.HKD","LU2543165471.USD","HK0000252160.HKD","09606","HK0000500386.USD","BK1161"],"gpt_icon":0},{"id":"2558659986","title":"每日卖空追踪 | 映恩生物-B 08月11日卖空量成交5200股，卖空比例为4.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558659986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558659986?lang=zh_cn&edition=fundamental","pubTime":"2025-08-11 16:30","pubTimestamp":1754901040,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间08月11日，跌2.35%，卖空量成交5200股%，较上一交易日减少66.45%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811172037a6df5332&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811172037a6df5332&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09606","HK0000252152.HKD","BK1161","LU2543165471.USD","HK0000252160.HKD","HK0000500386.USD"],"gpt_icon":0},{"id":"2558017631","title":"医药行业周报：礼来口服减肥药疗效低于预期 关注中国创新减肥药研发和出海进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2558017631","media":"爱建证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558017631?lang=zh_cn&edition=fundamental","pubTime":"2025-08-11 00:00","pubTimestamp":1754841600,"startTime":"0","endTime":"0","summary":"医药板块继续调整，跑输沪深300 指数。脑机接口迎来政策东风，七部门发布推动产业创新发展实施意见。礼来口服减肥药疗效低于预期，关注中国创新减肥药的研发和出海进展。另一方面，礼来Orforglipron 有效性不及预期，为中国小分子GLP-1 未来参与全球竞争留出了更大的发挥空间，目前恒瑞医药HRS-7535、成都闻泰VCT220、华东医药HDM1002 等已进入临床三期阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811144119a481616b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811144119a481616b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","09995","02359","688626","600276","09606","01877","603259","688520","01177","06821","01276","BK1574","688180","688331","SBHMY","BK1161","02616","688062","06990","09926","01093","02696","02268","02157"],"gpt_icon":0},{"id":"2557987529","title":"每日卖空追踪 | 映恩生物-B 08月08日卖空量成交5400股，卖空比例为3.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557987529","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557987529?lang=zh_cn&edition=fundamental","pubTime":"2025-08-08 16:30","pubTimestamp":1754641838,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间08月08日，跌0.49%，卖空量成交5400股%，较上一交易日增加100%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808180346a47d0675&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808180346a47d0675&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2543165471.USD","HK0000252160.HKD","HK0000252152.HKD","09606","BK1161","HK0000500386.USD"],"gpt_icon":0},{"id":"2557548820","title":"MSCI全球小型股指数调整在即 映恩生物-B(09606)等将被纳入","url":"https://stock-news.laohu8.com/highlight/detail?id=2557548820","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557548820?lang=zh_cn&edition=fundamental","pubTime":"2025-08-08 14:14","pubTimestamp":1754633690,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，8月8日，全球知名指数公司MSCI宣布2025年8月份的指数季度审议结果。在本次调整中，映恩生物-B(09606)等多家企业将被纳入MSCI全球小型股指数，正式跻身“全球资产”行列。此次调整将于8月26日收盘后生效。新纳入公司当日尾盘集合竞价成交将放大，系被动资金集中买入，短期股价影响有限；但长期来看，将在资金、估值和品牌端持续受益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1327237.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0708995401.HKD","BK4585","LU0289960550.SGD","LU2265009873.SGD","LU0672654240.SGD","LU0175139822.USD","09606","LU1267930730.SGD","LU2210149790.SGD","LU2095319765.USD","LU1804176565.USD","LU2210150020.SGD","LU0320765059.SGD","MSCI","LU0289961442.SGD","LU0109391861.USD","BK4588","LU0511384066.AUD","BK4112","LU0289739343.SGD","BK1161"],"gpt_icon":0},{"id":"2557455167","title":"映恩生物-B08月07日主力净流出178.2万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2557455167","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557455167?lang=zh_cn&edition=fundamental","pubTime":"2025-08-07 16:15","pubTimestamp":1754554522,"startTime":"0","endTime":"0","summary":"08月07日, 映恩生物-B股价跌6.14%，报收367.00元，成交金额9613.0万元，换手率0.30%，振幅7.62%，量比1.20。映恩生物-B今日主力资金净流出178.2万元，上一交易日主力净流入80万元。该股近5个交易日上涨4.80%，主力资金累计净流出879.0万元；近20日主力资金累计净流入389.2万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807171003a47a92e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807171003a47a92e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09606","BK1161"],"gpt_icon":0},{"id":"2557421303","title":"【IPO前哨】再次递表！旺山旺水生物估值超44亿，这些点值得关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2557421303","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557421303?lang=zh_cn&edition=fundamental","pubTime":"2025-08-06 10:16","pubTimestamp":1754446586,"startTime":"0","endTime":"0","summary":"2025年以来，维立志博-B（09887.HK）、拨康视云-B（02592.HK）、映恩生物-B（09606.HK）、脑动极光-B（06681.HK）在内的多家生物科技企业已经通过第18A章登陆港股市场。","market":"other","thumbnail":"https://images.finet.hk/photoLib/title/202508_1/2c18d3df-96d9-4ded-a96b-b96d580c488a.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202508_1/2c18d3df-96d9-4ded-a96b-b96d580c488a.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/6892bafa5a77128902028478","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["09606","02592","01877","BK1161","BK1189","BK1515","BK1583","06681"],"gpt_icon":1},{"id":"2557391171","title":"映恩生物-B08月05日主力净流入221.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2557391171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557391171?lang=zh_cn&edition=fundamental","pubTime":"2025-08-05 16:15","pubTimestamp":1754381747,"startTime":"0","endTime":"0","summary":"08月05日, 映恩生物-B股价涨12.74%，报收387.60元，成交金额1.4亿元，换手率0.42%，振幅14.49%，量比2.08。映恩生物-B今日主力资金净流入221.8万元，上一交易日主力净流出394.8万元。该股近5个交易日上涨5.98%，主力资金累计净流出677.6万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1230.7万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805165657a6d4252e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805165657a6d4252e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09606","BK1161"],"gpt_icon":0},{"id":"2557351217","title":"苏州基金：医疗投资八年征途","url":"https://stock-news.laohu8.com/highlight/detail?id=2557351217","media":"投资界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557351217?lang=zh_cn&edition=fundamental","pubTime":"2025-08-05 11:16","pubTimestamp":1754363760,"startTime":"0","endTime":"0","summary":"投资界拿到一组数据：迄今苏州基金在生物医药赛道已投资超20只子基金，累计实缴规模超30亿元。其中，成立于2017年的苏州基金堪称过去几年国内医疗健康领域最活跃的出资力量之一，留给创投圈深刻印象。这些年，苏州基金出资了启明创投、礼来亚洲基金旗下3期基金，彼此建立了深厚的合作关系。苏州基金合伙人崔远表示。作为苏州基金子基金金阖资本重仓的医疗项目，帝迈生物在苏州基金和金阖资本的共同推荐下，最终在苏州相城区落地。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805112321973459b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805112321973459b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09606"],"gpt_icon":0},{"id":"2557964733","title":"医药行业周报：IO2.0赛道进展喜人 静待下半年产业催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2557964733","media":"爱建证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557964733?lang=zh_cn&edition=fundamental","pubTime":"2025-08-05 00:00","pubTimestamp":1754323200,"startTime":"0","endTime":"0","summary":"医药板块本周+2.95%，排名1/31，跑赢沪深300 指数，创新药依然是板块重心。市场短期冲高回调，静待下半年创新药产业催化。IO 2.0 赛道进展喜人，下半年继续重点关注。1）基石药业：计划在ESMO 2025 大会公布全球首款PD-1 三抗的临床研究数据。4）中国生物制药：礼新医药与默沙东合作开发LM-299 进展顺利，7 月已完成技术转移，预计三季度将收到3 亿美金技术转移里程碑付款。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805194354a4768bf3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805194354a4768bf3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1997245094.SGD","09606","LU1997244956.HKD","LU1997245177.USD","02157","01877","LU1979443071.USD","09887","06821","BK0216","02696","SBHMY","09926","LU2495084118.USD","688331","09995","02616","688180","603259","688520","01541","01177","LU2328871848.SGD","01093","LU0456842615.SGD","LU1969619763.USD","LU2488822045.USD","06990","688062","LU1934453819.USD","02268"],"gpt_icon":0},{"id":"2556287969","title":"创新药东风浩荡：科创板未盈利IPO重新开闸","url":"https://stock-news.laohu8.com/highlight/detail?id=2556287969","media":"药智网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556287969?lang=zh_cn&edition=fundamental","pubTime":"2025-08-04 09:12","pubTimestamp":1754269930,"startTime":"0","endTime":"0","summary":"科创板未盈利IPO再度开闸，港股市场生物医药企业IPO热度前所未有，企业信心逐步恢复。01科创板未盈利IPO再开闸2019年，上海证券交易所新设科创板，并试点注册制，设置了五套上市标准。过去两年，科创板第五套IPO窗口关闭，超30家生物医药企业撤回科创板IPO申请。直到6月18日的陆家嘴论坛上，中国证监会主席吴清明确表示：将在创业板正式启用第三套标准，支持优质未盈利创新企业上市，并重启未盈利企业适用于科创板第五套标准上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804093952a4733e61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804093952a4733e61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01877","09606","688331","02617","01276","BK1574","688180","06978","09995"],"gpt_icon":0},{"id":"2556818781","title":"映恩生物-B08月01日主力净流出607.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2556818781","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556818781?lang=zh_cn&edition=fundamental","pubTime":"2025-08-01 16:15","pubTimestamp":1754036150,"startTime":"0","endTime":"0","summary":"08月01日, 映恩生物-B股价跌7.25%，报收324.80元，成交金额7476.4万元，换手率0.26%，振幅9.31%，量比1.39。映恩生物-B今日主力资金净流出607.8万元，上一交易日主力净流入103.2万元。该股近5个交易日下跌4.06%，主力资金累计净流出234.4万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入1485.8万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801165637a6cd6cf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801165637a6cd6cf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09606","BK1161"],"gpt_icon":0},{"id":"2555059241","title":"映恩生物-B07月29日主力净流入398.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2555059241","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555059241?lang=zh_cn&edition=fundamental","pubTime":"2025-07-29 16:15","pubTimestamp":1753776940,"startTime":"0","endTime":"0","summary":"07月29日, 映恩生物-B股价涨2.17%，报收368.00元，成交金额8050.2万元，换手率0.25%，振幅5.05%，量比1.10。映恩生物-B今日主力资金净流入398.3万元，上一交易日主力净流出128.1万元。该股近5个交易日上涨12.09%，主力资金累计净流入487.5万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1629.7万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729165711a46952e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729165711a46952e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09606"],"gpt_icon":0},{"id":"2555707951","title":"“冠科系”新锐冲击港交所，翰思艾泰的“下一代双抗免疫治疗”能否大放异彩？","url":"https://stock-news.laohu8.com/highlight/detail?id=2555707951","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555707951?lang=zh_cn&edition=fundamental","pubTime":"2025-07-29 08:13","pubTimestamp":1753748026,"startTime":"0","endTime":"0","summary":"6月2日，港交所披露，聚焦新一代双抗免疫疗法的创新药企翰思艾泰提交上市申请书。在他的领导下，翰思艾泰专注于具有可成药结构及靶向效应的抗体分子的工程化，开创具有较高安全性及有效性的下一代免疫疗法。押注下一代双抗免疫疗法，成为契合翰思艾泰“提供新一代肿瘤免疫治疗”的关键战略。从靶点来看，翰思艾泰围绕“识别下一代免疫检查点靶点”，如靶向CTLA-4、SIPRa/CD47、OX40，开发具有抗肿瘤协同效应的双功能或多功能分子。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729081611a4687217&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729081611a4687217&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HKXCY","SGXZ90724238.SGD","LU0061477393.USD","01276","LU0417516902.SGD","LU0348816934.USD","LU0572944931.SGD","LU0577902371.SGD","LU0516422952.EUR","LU1366334578.USD","LU1831875114.USD","HEXmain","LU0149721374.USD","09606","09995","LU2226246903.HKD","01801","LU0762542818.HKD","LU1481107354.HKD","LU0211977185.USD","LU1105468828.SGD","LU0084288322.USD","00388","09926","LU1242518931.SGD","LU0096374516.USD","LU0348825331.USD","LU0516422440.USD","LU0348827113.USD","LU0048597586.USD","LU0594300179.USD","80388","LU1282648689.USD","LU1993786604.SGD","01530","BK1131","LU0831103253.SGD","LU0594300419.USD","LU0149534421.HKD","LU0348735423.USD","LU0540923850.HKD","02157","LU0165289439.USD","LU1023057109.AUD","LU0106959298.USD","LU0577902298.EUR","LU0630378692.HKD","LU1807302812.USD","LU0873338254.USD","688331","LU0501845795.SGD","02142","LU0140636845.USD","LU0577902611.USD","SG9999001093.SGD","BK1610","LU1328277881.USD","09969","688428","LU1242518857.USD","LU0043850808.USD"],"gpt_icon":1},{"id":"2554723441","title":"三生制药与辉瑞全球授权协议生效|先声再明FDA获批临床|映恩生物新一代HER3获FDA快速通道资格","url":"https://stock-news.laohu8.com/highlight/detail?id=2554723441","media":"中国医药创新促...","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554723441?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 14:01","pubTimestamp":1753682480,"startTime":"0","endTime":"0","summary":"药械审批先声再明 SIM06867月21日，先声药业旗下公司先声再明宣布，其自主研发的靶向FGFR2b的抗体偶联药物SIM0686的临床试验申请已于近日获美国食品药品监督管理局批准。7月24日，三生制药宣布，与辉瑞就PD-1/VEGF双抗SSGJ-707达成的全球授权协议于今日正式生效。双方同意，在5月20日公司公告将获得12.5亿美元首付款的基础上，三生制药将额外获得1.5亿美元款项，以进一步授予辉瑞在中国内地独家开发和商业化SSGJ-707的权利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728140811a4670e13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"f04919e909abe9f76d177e0aaa2c6d54","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728140811a4670e13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688331","09606","02096","688658","BK1161","BK1583","01530","PFE","BK1593","09995","00512"],"gpt_icon":0},{"id":"2554958741","title":"中国创新药出海“爆单”，半年揽660亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554958741","media":"中国企业家杂志","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554958741?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 07:59","pubTimestamp":1753660751,"startTime":"0","endTime":"0","summary":"巨额交易频现是眼下中国创新药“出海”的一大亮点，其中最引人注目的是一笔来自三生制药的交易。据上述主题报告不完全统计，在MNC与中国创新药企的交易中，默沙东、阿斯利康、礼来制药排名前三甲，其中默沙东自2015年以来，与中国药企的重磅交易总计近20件。随着技术的持续迭代，以及与国际合作的深化，中国创新药出海将进入“质量与规模双升”的新阶段。今年6月20日，联邦制药对外表示已收到来自诺和诺德的预付款1.8亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728092118a6c4d488&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728092118a6c4d488&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","06160","01530","MRK","02142","01801","BK1583","AZN","NVO","09606","BK1574","01276","LU2488822045.USD","BK1161","06978","PFE","02162","600276","LU1969619763.USD","688235","LU2328871848.SGD","ONC","688062","03933"],"gpt_icon":0},{"id":"2553917788","title":"当3000亿资金涌向18A新股","url":"https://stock-news.laohu8.com/highlight/detail?id=2553917788","media":"氨基观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553917788?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 19:58","pubTimestamp":1753358280,"startTime":"0","endTime":"0","summary":"7月22日维立志博完成认购，数据显示其融资申购金额飙至惊人的3300亿港元，散户认购倍数超3000倍。目前其暗盘交易显示，股价已经大涨超过90%，总市值超130亿港元。/ 02 /成功样本港股18A新股受追捧的盛况，并非始于维立志博。二级市场融资渠道已显著畅通：截至目前，已有10家药企完成IPO，募资总额逼近200亿港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724203654a46157fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724203654a46157fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09926","01952","LU1064131003.USD","LU2488822045.USD","688235","06855","01167","01228","BK0239","09995","01530","LU2148510915.USD","688506","LEGN","688331","SBHMY","09606","06160","LU1064130708.USD","AAPG","01177","02616","ONC"],"gpt_icon":0},{"id":"2553563200","title":"映恩生物-B07月24日获主力加仓245.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553563200","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553563200?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 16:15","pubTimestamp":1753344951,"startTime":"0","endTime":"0","summary":"07月24日, 映恩生物-B股价涨5.10%，报收333.60元，成交金额6266.8万元，换手率0.22%，振幅6.24%，量比0.76。映恩生物-B今日主力资金净流入245.1万元，连续4日净流入，上一交易日主力净流入53.3万元。该股近5个交易日上涨1.40%，主力资金累计净流入371.2万元，其中3个交易日为股价下跌时净流入；近20日主力资金累计净流入831.7万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724170101a460edf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724170101a460edf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09606"],"gpt_icon":0},{"id":"2553919402","title":"1500万美元首付款，又一款国产CAR-T出海；赛诺菲16亿美元收购疫苗企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2553919402","media":"Ofweek光电信息网","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553919402?lang=zh_cn&edition=fundamental","pubTime":"2025-07-23 14:02","pubTimestamp":1753250520,"startTime":"0","endTime":"0","summary":"又一款国产创新药出海。科弈药业将获1500万美元近期里程碑付款。赛诺菲不强疫苗版图。/ 03 / 海外药闻1）赛诺菲16亿美元收购疫苗企业7月22日， 赛诺菲宣布收购总部位于英国伦敦的生物技术公司Vicebio。根据协议条款，赛诺菲将以总计11.5亿美元的预付款项收购Vicebio的全部股本，并根据开发和监管里程碑的实现情况支付最高达4.5亿美元的潜在里程碑款项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072314243797b1e551&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072314243797b1e551&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688351","09606","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":155,"code":"91000000","status":"200"}]}}